home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Gene therapy for liver metastases

  July, 4 2001 2:31
your information resource in human molecular genetics
gene therapy for livermetastases

Because hepatocytes are constantly exposed to portal blood, the liver can be readily transduced with injected transgenes. Noting that this organ is also particularly prone to taking up metastatic colorectal tumor cells, Tada and colleagues have proposed to use gene therapy to render the liver a less hospitable environment for exogenous tumors. The authors show here that following intravenous injection of recombinant adenovirus, the antitumor cytokine interferon b (IFNb) is efficiently expressed in mouse hepatocytes, where it persists over a period of weeks. The expression of the cytokine not only blocks the progression of human micrometastases, but can also eliminate existing human tumors in the treated mice, a condition that better mimics the likely clinical presentation of the disease. Taking advantage of the fact that human and murine IFNb fail to recognize each others’ receptors Tada et al. also show that IFNb can play two beneficial roles, causing cytotoxicity directly in the implanted tumor cells and stimulating host NK cells to attack the tumor cells and promote tumor regression.

Message posted by: Wouter Kalle

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.